69 Best Biotech Startups in Switzerland to Watch in 2024

Advanced allosteric modulator therapeutics developer for neurological disorders.

Total Raised: $63.00M

Last Funding: $63.00M (Series A)

Novel antiobiotic researcher to fight antimicrobial resistance.

Total Raised: $34.47M

Last Funding: $13.57M (Series C)

Clinical-stage central nervous system (CNS) technology.

Total Raised: $169.29M

Last Funding: $110.29M (Series B)

Producer of ethanol-free perfume pearls.

Total Raised: $16.07M

Last Funding: $10.44M (Series A)

Gene and cell therapy manufacturing.

Total Raised: $50.42M

Last Funding: $50.42M (Series A)

Antibody discovery and human immune repertoire analysis platform.

Total Raised: $45.28M

Last Funding: $2.30M (Series A)

Viral vector-based cancer vaccines developer.

Total Raised: $141.79M

Last Funding: $82.89M (Series C)

Developer of cell macroencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier.

Total Raised: $3.86M

Last Funding: $3.86M (Seed)

Therapeutics developer for mast cell-mediated diseases.

Total Raised: $3.50M

Last Funding: $3.50M (Seed)

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

Total Raised: $59.53M

Last Funding: $59.53M (Series A)

Immunotherapy platform for cancer.

Total Raised: $93.33M

Last Funding: $74.00M (Unknown)

Self-adjuvanting and multi-antigen vaccine technology platform.

Total Raised: $3.00M

Last Funding: $3.00M (Series A)

Developer of an antibody-drug conjugates (ADCs).

Total Raised: $26.81M

Last Funding: $2.70M (Seed)

Biotechnology platform developing therapies by investing in people and ideas.

Total Raised: $25.31M

Last Funding: $0.00M (Unknown)

Medical robotics company.

Total Raised: $12.00M

Last Funding: $12.00M (Series A)

Manufacturer of drugs to combat the effects of ageing.

Total Raised: $10.90M

Last Funding: $10.90M (Series A)

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Clinical stage artificial heart valve.

Total Raised: $2.74M

Last Funding: $2.74M (Series A)

Guided medical devices cardiovascular procedures.

Total Raised: $4.02M

Last Funding: $4.02M (Series B)

Developer of treatments for neurodegenerative diseases.

Total Raised: $100.00M

Last Funding: $100.00M (Series C)

True precision medicine through single-cell science

Total Raised: $5.90M

Last Funding: $1.80M (Series A)

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

Total Raised: $23.00M

Last Funding: $2.60M (Seed)

Platform for observing live cells in 3D without damaging them.

Total Raised: $22.20M

Last Funding: $20.00M (Unknown)

Platform providing digital assessments and therapies for patient treatment and rehabilitation.

Total Raised: $125.00M

Last Funding: $125.00M (Unknown)

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

Glycanengineering platform.

Total Raised: $49.29M

Last Funding: $49.29M (Series A)

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.

Total Raised: $80.00M

Last Funding: $80.00M (Series C)

Clinical-stage biotechnology developing treatments for cancer.

Total Raised: $85.50M

Last Funding: $85.50M (Series B)

Program to increase human lifespan.

Total Raised: $5.86M

Last Funding: $5.86M (Seed)

Non-invasive treatment for heart arrhythmias.

Total Raised: $15.70M

Last Funding: $15.70M (Series A)

Small molecule mitophagy inducers developer.

Total Raised: $20.66M

Last Funding: $20.66M (Series A)

Treatments that improve the lives of cancer patients with innovative approaches.

Total Raised: $26.73M

Last Funding: $26.73M (Series C)

Compounds for immunotherapy and metabolic diseases.

Total Raised: $1.63M

Last Funding: $1.63M (Seed)

Software platform that accelerates innovation in the pharmaceutical industry.

Total Raised: $12.70M

Last Funding: $12.70M (Seed)

Generative AI platform for protein design and engineering.

Total Raised: $29.70M

Last Funding: $5.70M (Unknown)

Platform offering tools to enhance the development of personalized and precision medicine.

Total Raised: $35.31M

Last Funding: $20.31M (Unknown)

Clinical-stage biopharmaceutical company developing drugs for rare diseases.

Total Raised: $16.00M

Last Funding: $16.00M (Series A)

Biotech company creating meat and dairy alternatives using biomass and precision fermentation techniques.

Total Raised: $8.10M

Last Funding: $8.10M (Seed)

Gene therapy platform.

Total Raised: $6.81M

Last Funding: $6.81M (Seed)

Antibiotic resistance test.

Total Raised: $9.17M

Last Funding: $9.17M (Series B)

Tumor immunotherapy drug developer.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

Platform engineering next-generation T cell receptor therapies.

Total Raised: $15.80M

Last Funding: $15.80M (Seed)

Clinical biotech firm focused on revolutionizing cell invasion research.

Total Raised: $4.70M

Last Funding: $4.70M (Seed)

Quantum sensing technology for nanoscale imaging.

Total Raised: $7.08M

Last Funding: $4.46M (Series A)

RNA sequencing and transcriptomics analysis platform.

Total Raised: $3.29M

Last Funding: $3.18M (Seed)

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

Total Raised: $2.33M

Last Funding: $2.16M (Seed)

Precision medicine developer for neuropsychiatric and neurological disorders.

Total Raised: $13.60M

Last Funding: $13.60M (Series B)

Pathogen detection technology that provides accurate results in under 2 hours.

Total Raised: $6.39M

Last Funding: $6.39M (Series B)

Biotechnology company creating vaccines and immunotherapies.

Total Raised: $8.02M

Last Funding: $8.02M (Series B)

Platform for sharing and interacting with video games using emotions.

Total Raised: $1.60M

Last Funding: $1.60M (Unknown)

Rheon focuses on the development of first-in-class glaucoma drainage devices.

Total Raised: $6.29M

Last Funding: $6.29M (Unknown)

Renewable system for onsite production of solar fuel and power, offering a cleaner, greener, and cost-effective solution.

Total Raised: $2.00M

Last Funding: $2.00M (Seed)

Platform focusing on the discovery and development of next-generation RNA-based drugs.

Total Raised: $6.42M

Last Funding: $6.42M (Seed)

Platform that identifies the ideal treatment for each cancer patient’s disease.

Total Raised: $7.62M

Last Funding: $7.62M (Unknown)

Accurate monitoring and treatment platform for sleep bruxism and sleep apnea.

Total Raised: $3.00M

Last Funding: $3.00M (Seed)

Bloom Biorenewables is making biomass a true alternative to petroleum.

Total Raised: $3.44M

Last Funding: $3.44M (Unknown)

Device improving comfort during gynecological procedures.

Total Raised: $5.00M

Last Funding: $5.00M (Unknown)

Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.

Total Raised: $3.90M

Last Funding: $3.90M (Pre Seed)

Solutions that advance neuroscience research and speed up preclinical drug discovery.

Total Raised: $4.50M

Last Funding: $4.50M (Series A)

Preventive health technology.

Total Raised: $4.27M

Last Funding: $4.27M (Pre Seed)

System improving honey bee health by using heat to combat the varroa mite.

Total Raised: $1.13M

Last Funding: $1.13M (Unknown)

Molecular analysis technology developer.

Total Raised: $1.90M

Last Funding: $1.90M (Pre Seed)

Preclinical-stage oncology platform.

Total Raised: $1.40M

Last Funding: $1.40M (Seed)

Self-testing kit provider for quick, at-home medical results.

Total Raised: $1.73M

Last Funding: $1.73M (Seed)

Biotechnology company developing treatments to enhance immune system responses.

Total Raised: $0.15M

Last Funding: $0.15M (Pre Seed)

Bio-based and biodegradable foam solutions for fast disposables.

Total Raised: $0.16M

Last Funding: $0.16M (Pre Seed)

AI-powered biotech research platform.

Total Raised: $0.64M

Last Funding: $0.53M (Seed)

The Tokenised Cloud - Sustainable, Decentralised

Total Raised: $2.00M

Last Funding: $2.00M (Pre Seed)

Biotech firm focused on creating personalized molecular therapies for cancer patients.

Total Raised: $1.10M

Last Funding: $1.10M (Seed)